NEW

Masimo Announces iSirona Connectivity Hub

Masimo has announced the global launch of iSirona, a compact, versatile connectivity hub designed to maximize interoperability across the continuum of care.

DJO Acquires Trilliant Surgical

DJO LLC, a global provider of medical technologies to get and keep people moving, has announced the acquisition of Trilliant Surgical, a national provider of foot and ankle orthopedic implants.

DePuy Synthes Receives 510(k) FDA Clearance for VELYS™ Robotic-Assisted Solution Designed for Use with the ATTUNE Total Knee System

The Johnson & Johnson Medical Devices Companies announced that DePuy Synthes has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the VELYS Robotic-Assisted Solution designed for use with the ATTUNE® Total Knee System and its cleared indications for use.

Philips to Acquire Capsule Technologies Inc.

Royal Philips has signed an agreement to acquire Capsule Technologies Inc., a provider of medical device integration and data technologies for hospitals and healthcare organizations.

eZspand Expandable Cage Released

eZspand™ cage

Zavation Medical Products, an innovative designer and manufacturer of high-quality spinal implants, instruments, MIS procedural kits, and biologics headquartered in Flowood, Mississippi, has announced the launch of eZspand, an expandable lumbar interbody fusion device.

eZspand, the latest addition to Zavation’s portfolio, features unmatched expandable precision paired with continual expansion to provide an optimized fit for each patient. This optimized fit allows for enhancement of structural stability and improved sagittal balance. eZspand does not require secondary locking, minimizing procedural steps. Each implant expands to 4.5mm from the insertion height to create a large graft window that facilitates fusion. The benefits of continuous height adjustment (not incremental) up to 4.5mm expansion paired with no secondary locking step separate eZspand from its competitors.

Zavation’s market share and active surgeon base continues to rapidly grow given the company’s ability to adapt to surgeon/patient needs, consistently upgrade its instruments, and engineer devices with incomparable simplicity and precision. Zavation’s sustained investment in research and development will further enhance its expandable technologies and accelerate market share and active surgeon base gains.

“Our product development team’s dedication to creatively blending simplicity and precision in a robust product design has produced an expandable product that we believe is the new gold standard in facilitating patient fusion in a seamless and simplified procedure,” said Jeffrey Johnson, CEO. “With restoration of alignment being of critical importance, the eZspand was developed to help surgeons address stability and sagittal alignment, while maximizing lordotic correction. This product is an example of Zavation’s commitment to offering innovative and differentiated products in conjunction with market leading customer service to best serve our surgeons and distributor network.”

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X